AstraZeneca PLC AZN shares rallied 2.39% to £110.52 Tuesday, on what proved to be an all-around great trading session for the ...
Nanobiotix NBTX shares were up around 13% during the pre-market hours on Tuesday after the company announced that it has ...
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
President Trump rescinded an executive order that prompted the creation of three Medicare drug-pricing experiments ...
Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...
Just when you may have finally gotten your head around the opportunity in artificial intelligence (AI), a new investment ...
Uniphar, a leading global partner to pharmaceutical and medtech manufacturers, announces the appointment of Isaac Batley as Global Head of Medical and Scientific Communications. In this pivotal role, ...
AstraZeneca's bold vision for a cutting-edge vaccine facility in Speke is caught in a web of delays, leaving the biotech ...
Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca" or the "Company") of a class action securities ...
In England, about 600 people will benefit from the daily pill that helps treat lung cancer as it becomes routinely available on the NHS.